نتایج جستجو برای: pls3

تعداد نتایج: 154  

Journal: :Molecular cancer therapeutics 2014
Yan Ning Armin Gerger Wu Zhang Diana L Hanna Dongyun Yang Thomas Winder Takeru Wakatsuki Melissa J Labonte Sebastian Stintzing Nico Volz Yu Sunakawa Stefan Stremitzer Rita El-Khoueiry Heinz-Josef Lenz

Tumor recurrence after curative resection remains a major problem in patients with locally advanced colorectal cancer treated with adjuvant chemotherapy. Genetic single-nucleotide polymorphisms (SNP) may serve as useful molecular markers to predict clinical outcomes in these patients and identify targets for future drug development. Recent in vitro and in vivo studies have demonstrated that the...

Journal: :Cancer research 2013
Takehiko Yokobori Hisae Iinuma Teppei Shimamura Seiya Imoto Keishi Sugimachi Hideshi Ishii Masaaki Iwatsuki Daisuke Ota Masahisa Ohkuma Takeshi Iwaya Naohiro Nishida Ryunosuke Kogo Tomoya Sudo Fumiaki Tanaka Kohei Shibata Hiroyuki Toh Tetsuya Sato Graham F Barnard Takeo Fukagawa Seiichiro Yamamoto Hayao Nakanishi Shin Sasaki Satoru Miyano Toshiaki Watanabe Hiroyuki Kuwano Koshi Mimori Klaus Pantel Masaki Mori

Circulating tumor cells (CTC) in blood have attracted attention both as potential seeds for metastasis and as biomarkers. However, most CTC detection systems might miss epithelial-mesenchymal transition (EMT)-induced metastatic cells because detection is based on epithelial markers. First, to discover novel markers capable of detecting CTCs in which EMT has not been repressed, microarray analys...

Journal: :Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2014
Somayyeh Fahiminiya Jacek Majewski Hadil Al-Jallad Pierre Moffatt John Mort Francis H Glorieux Paul Roschger Klaus Klaushofer Frank Rauch

Mutations in PLS3 have been identified as a cause of bone fragility in children, but the bone phenotype associated with PLS3 mutations has not been reported in detail. PLS3 is located on the X chromosome and encodes the actin-binding protein plastin 3. Here we describe skeletal findings in 4 boys from 2 families with mutations in PLS3 (c.994_995delGA; p.Asp332* in family 1; c.1433T > C; p.Leu47...

Journal: :Science 2008
Gabriela E Oprea Sandra Kröber Michelle L McWhorter Wilfried Rossoll Stefan Müller Michael Krawczak Gary J Bassell Christine E Beattie Brunhilde Wirth

Homozygous deletion of the survival motor neuron 1 gene (SMN1) causes spinal muscular atrophy (SMA), the most frequent genetic cause of early childhood lethality. In rare instances, however, individuals are asymptomatic despite carrying the same SMN1 mutations as their affected siblings, thereby suggesting the influence of modifier genes. We discovered that unaffected SMN1-deleted females exhib...

Journal: :Scientific reports 2015
María G Boza-Morán Rebeca Martínez-Hernández Sara Bernal Klaus Wanisch Eva Also-Rallo Anita Le Heron Laura Alías Cécile Denis Mathilde Girard Jiing-Kuan Yee Eduardo F Tizzano Rafael J Yáñez-Muñoz

Spinal muscular atrophy (SMA) is a neuromuscular disease caused by mutations in Survival Motor Neuron 1 (SMN1), leading to degeneration of alpha motor neurons (MNs) but also affecting other cell types. Induced pluripotent stem cell (iPSC)-derived human MN models from severe SMA patients have shown relevant phenotypes. We have produced and fully characterized iPSCs from members of a discordant c...

Journal: :Hormone research in paediatrics 2015
Anders J Kämpe Riikka E Mäkitie Outi Mäkitie

Recent developments in genetic technology have given us the opportunity to look at diseases in a new and more detailed way. This Mini Review discusses monogenetic forms of childhood-onset primary osteoporosis, with the main focus on osteoporosis caused by mutations in WNT1 and PLS3, two of the most recently discovered genes underlying early-onset osteoporosis. The importance of WNT1 in the accr...

Journal: :New England Journal of Medicine 2013

2015
Anna Lyberopoulou Gerasimos Aravantinos Efstathios P. Efstathopoulos Nikolaos Nikiteas Penelope Bouziotis Athina Isaakidou Apostolos Papalois Evangelos Marinos Maria Gazouli

Circulating tumor cells (CTCs) provide a non-invasive accessible source of tumor material from patients with cancer. The cellular heterogeneity within CTC populations is of great clinical importance regarding the increasing number of adjuvant treatment options for patients with metastatic carcinomas, in order to eliminate residual disease. Moreover, the molecular profiling of these rare cells m...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید